MEDZnMORE’s Tabiyat.Pk Companions with Hayat Kimya to Provide High quality Mom and Child Merchandise –

MEDZnMORE’s tabiyat.pk signed an settlement with Hayat Kimya, fifth largest producers of child diapers, to provide its shoppers quick access to their merchandise. With this partnership, the web platform will be capable to provide a bigger vary of babycare, mothercare and female merchandise.

Advertisement

The settlement was signed by Asad Khan, CEO MEDZnMORE and Ahsan Tariq, Space Gross sales Supervisor Hayat Kimya. The partnership occasion was hosted at tabiyat.pk’s Lahore workplace and was attended by senior executives from each firms.

The net platform has already been providing an incredible number of mom and child merchandise together with pharmaceutical and different healthcare classes. With the latest partnership with Hayat Kimya, tabiyat.pk will be capable to provide one of the vital sought-after diapers, Molfix and sanitary pads, Molped together with a number of different merchandise.

Advertisement

tabiyat.pk is a vertical of the main health-tech startup MEDZnMORE, based with a imaginative and prescient to reshape healthcare by offering quick access to high quality healthcare. Based in 2020, the web platform has served prospects throughout Pakistan. They’ve invested closely in constructing purpose-built temperature-controlled warehouses throughout Pakistan to seamlessly fulfill operational wants.

The net platform has additionally beforehand partnered with main market leaders akin to Getz Pharma, GSK, Protect, Mothercare and different market leaders to offer 100% genuine healthcare merchandise to its prospects; aligning with their mission to eradicate counterfeit medicines within the nation.

Advertisement

The beginning-up earlier secured $11.5 Million in its pre-series A spherical, making it the biggest health-tech funding in Pakistan. Other than partnering with the main producers, tabiyat.pk has numerous initiatives within the pipeline to supply the viewers higher entry to healthcare merchandise.

Advertisement

Advertisement

Leave a Comment